Dispersol Technologies, Inc.
DisperSol uses its pharmaceutical processing technology and equipment to develop drug compositions that otherwise can not be processed
Dispersol is a high growth coompany with a development program to reformulate and manufacture challenging existing drugs. DisperSol is in advanced development of a tamper resistant /abuse deterrent platform for the manufacture of opioid drugs, that are in testing for 7 global pharma companies. The Company also is developing an oncology drug. Company has 3 issued patents and 3 patent applications. Currently expanding 3X capacity by Q4 2014 .